News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Skin cancer treatment selfie goes viral, has public health lessons
Researchers led by UNC Lineberger's Seth Noar, PhD, analyzed the impact of one viral social media post in generating awareness about skin cancer.
Study shows survival benefits for seeing an NCI specialist for multiple myeloma
Preliminary findings presented at the 59th Annual American Society of Hematology Annual Meeting point to survival benefits for seeing a specialist for multiple myeloma in North Carolina.
Immunotherapy could be beneficial for relapsed acute myeloid leukemia
Researchers led by UNC Lineberger's Joshua Zeidner, MD, presented preliminary results from an ongoing phase II trial of the checkpoint inhibitor pembrolizumab and chemotherapy for relaposed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta.
Using software, researchers predict tumor markers that could be immune targets
UNC Lineberger researchers led by Benjamin Vincent, MD, reported preliminary findings at the 59th ASH Annual Meeting in Atlanta that are an early step in the overall plan to use the software’s predictions to develop immune-based therapies for leukemia.
Biological factors don't completely explain racial disparities for ‘good prognosis’ breast cancer
The biological features of patients’ tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn’t explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.